It was reported an increase on Hutchison China Meditech Limited – American Deposi (NASDAQ:HCM)’s shares shorted with 5.03%. It was issued in March by FINRA the 2.55M shares shorted on HCM. That’s 5.03% up from 2.43 million shares. 18 days will cost HCM with 138,100 average volume to recover its former position. Hutchison China Meditech Limited – American Deposi float short is 5.98%.
The stock decreased 3.80% or $1.13 during the last trading session, touching $28.58.Hutchison China MediTech Limited has volume of 119,216 shares. Since March 24, 2018 HCM has declined 23.51% and is downtrending. HCM underperformed the S&P500 by 27.88%.
Hutchison China MediTech Limited, a biopharmaceutical company, engages in the research, development, manufacture, and sale of pharmaceuticals and healthcare products primarily in the People's Republic of China and Hong Kong.The firm is valued at $3.83 billion. It operates through Innovation Platform and Commercial Platform divisions.Currently it has negative earnings. The firm discovers and develops therapeutics in oncology and autoimmune diseases, as well as provides research and development services; and develops, makes, distributes, markets, and sells prescription and over-the-counter pharmaceutical products, and consumer health products under the Baiyunshan and Shang Yao brands.
For more Hutchison China MediTech Limited (NASDAQ:HCM) news released recently go to: Nasdaq.com, Nasdaq.com, Nasdaq.com, Fool.com or Seekingalpha.com. The titles are as follows: “Workday (WDAY) Q4 Earnings & Revenues Surpass Estimates – Nasdaq” released on March 01, 2019, “Ultimate Software (ULTI) Up 0.2% Since Last Earnings Report: Can It Continue? – Nasdaq” on March 06, 2019, “Asure Software Workplace IoT Sensors Announced as Finalist in Prestigious 2019 Edison Awards – Nasdaq” with a publish date: March 05, 2019, “After Another Strong Quarter, Workday Now Claims 40% of the Fortune 500 as Customers – Motley Fool” and the last “Chi-Med commercially launches Fruquintinib capsules – Seeking Alpha” with publication date: November 26, 2018.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.